XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 6 Months Ended 10 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2022
Cash flows from Operating Activities:        
Net income $ 1,870,068 $ 15,556,968 $ 9,169,605 $ 24,256,284
Adjustments to reconcile net income to net cash used in operating activities:        
Income from investments held in Trust Account (5,734,105) (528,157) (21,694) (5,091,197)
Changes in fair value of warrant liability and sponsor loans (606,200) (15,696,000) (11,431,645) (21,332,800)
Fair value of Private Placement Warrants in excess of purchase price     886,420  
Offering costs attributable to warrant liability     1,035,747  
Changes in operating assets and liabilities:        
Prepaid expenses 159,371 160,445 (720,467) 389,014
Due to related party (5,850) 4,718 2,727 7,297
Accrued income taxes 33,626 57,969   485,207
Accounts payable and accrued expenses 2,550,078 (229,379) 224,438 (229,869)
Net cash used in operating activities (1,733,012) (673,436) (854,869) (1,516,064)
Cash flows from Investing Activities:        
Cash withdrawn from Trust Account to pay taxes 1,911,013     822,658
Cash withdrawn from Trust Account in connection with redemptions 317,387,323      
Investment of cash in Trust Account     (351,900,000)  
Net cash provided by investing activities 319,298,336   (351,900,000) 822,658
Cash flows from Financing Activities:        
Redemption of Common Stock (317,387,323)      
Proceeds from sale of Units, net of underwriters' discount     338,100,000  
Proceeds from issuance of sponsor loans     6,900,000  
Proceeds from sale of common stock to initial shareholders     25,000  
Proceeds from issuance of promissory note to related party     175,000  
Payment of offering costs     (455,576)  
Repayment of promissory note to related party     (175,000)  
Net cash used in financing activities (317,387,323)   353,969,424  
Net change in cash 178,001 (673,436) 1,214,555 (693,406)
Cash, beginning of the period 521,149 1,214,555 0 1,214,555
Cash, end of the period 699,150 541,119 1,214,555 521,149
Non-cash financing transactions:        
Increase in redemption value of shares subject to possible redemption 4,450,363 $ 218,133   $ 3,743,935
Non-cash contribution - non-redemption agreements 884,554      
Excise tax payable attributable to redemption of common stock $ 3,173,873      
Initial classification of warrant liability     28,676,645  
Deferred Underwriting Fee Payable     12,075,000  
Offering costs included in accounts payable and accrued offering expenses     $ 85,000